Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001179110-21-011076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-16 | 2021-12-14 | TBPH | SVP, Comm, Medical Affairs | A - Grant | $0.00 | +27.5K | 347.5K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-12-14 | A | A | 27,500 | $0.00 | 347,451 | D | — | — |